Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,937
datasets available to search
ShareScore release 0.9.0
Dataset results
2,937 results for “Multiple Myeloma”
Vaccine Responses in Patient With Multiple Myeloma and Non-Hodgkin Lymphoma After CAR-T Treatment
ClinicalTrials.gov study NCT06784167. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Talquetamab With Other Anticancer Therapies in Participants With Multiple Myeloma
ClinicalTrials.gov study NCT05050097. IPD Sharing: YES. Countries: 6. Publications: 0.
Frontline T-cell Engager vs Autologous Stem Cell Transplant (ASCT) and Measurable Residual Disease (MRD)-Guided Sequential Intensification thERapy in Multiple Myeloma
ClinicalTrials.gov study NCT06974786. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of Ciltacabtagene Autoleucel and Talquetamab for the Treatment of Participants With High-Risk Multiple Myeloma
ClinicalTrials.gov study NCT06550895. IPD Sharing: YES. Countries: 2. Publications: 0.
Bortezomib, Arsenic Trioxide, and Melphalan in Treating Patients Undergoing an Autologous Stem Cell Transplant For Multiple Myeloma
ClinicalTrials.gov study NCT00504101. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Novel Support Options in Autologous Stem Cell Transplant for Multiple Myeloma
ClinicalTrials.gov study NCT02274519. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Noscapine HCl (CB3304 ) in Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT00912899. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Early Response-adapted Intensification of Induction Chemotherapy in Patients With Newly Diagnosed Multiple Myeloma (MM)
ClinicalTrials.gov study NCT01114048. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Evaluate the Safety, Tolerability and Efficacy of Intravenous TAK-573 as Part of Combination Therapy in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
ClinicalTrials.gov study NCT04392648. IPD Sharing: YES. Countries: 0. Publications: 0.
Retrospective Study to Describe Carfilzomib Use on Patients With Relapsed Multiple Myeloma in France in the Context of Carfilzomib Nominative Expanded Access and Compassionate Use
ClinicalTrials.gov study NCT04811508. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Anti-neoplastic Treatment, Based on PRO Data Reported Through a MHealth App Solution in Multiple Myeloma
ClinicalTrials.gov study NCT05724966. IPD Sharing: NO. Countries: 1. Publications: 0.
Samarium Sm 153 Lexidronam Pentasodium Combined With Zoledronic Acid or Pamidronate in Treating Patients With Relapsed or Refractory Multiple Myeloma and Bone Pain
ClinicalTrials.gov study NCT00482378. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Comparison of the Effects of Apixaban on Thrombin Generation in Patients With de Novo Multiple Myeloma
ClinicalTrials.gov study NCT06474182. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Evaluation of a PREHABilitation Protocol Using Adapted Physical Activity (APA) for Multiple Myeloma Patients Eligible for Intensive Autologous Stem Cell Transplantation Treatment
ClinicalTrials.gov study NCT06789003. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Elotuzumab in Patients With Multiple Myeloma Before and After Peripheral Stem Cell Autologous Graft
ClinicalTrials.gov study NCT03393273. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Selvigaltin With Standard of Care Treatment for the Treatment of Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT07082270. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Vaccination With Peptides From Anti-apoptotic Proteins in Relapsed Multiple Myeloma
ClinicalTrials.gov study NCT01272466. IPD Sharing: Not stated. Countries: 1. Publications: 0.
PAD Combination Therapy Followed by Thal/Dex for Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT00319865. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Early Detection of Multiple Myeloma to Fight Cancer Disparities: A Screening and Patient Navigation Program
ClinicalTrials.gov study NCT05831358. IPD Sharing: NO. Countries: 1. Publications: 0.
First Line Treatment Trial in Multiple Myeloma, Finnish Myeloma Group- Multiple Myeloma 02
ClinicalTrials.gov study NCT01790737. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.